BKM Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489K Sell
408
-9
-2% -$9.2K 0.17% 106
2026
Q1
$384K Sell
417
-2
-0.5% -$2.03K 0.14% 112
2025
Q4
$450K Buy
419
+60
+17% +$57.4K 0.16% 107
2025
Q3
$274K Sell
359
-61
-15% -$45.4K 0.1% 135
2025
Q2
$327K Hold
420
0.13% 125
2025
Q1
$347K Sell
420
-60
-13% -$49.9K 0.14% 123
2024
Q4
$371K Buy
480
+221
+85% +$183K 0.15% 121
2024
Q3
$229K Buy
+259
New +$233K 0.09% 154
2024
Q2
Sell
-241
Closed -$187K 174
2024
Q1
$187K Sell
241
-9
-4% -$6.41K 0.08% 165
2023
Q4
$146K Buy
+250
New +$146K 0.06% 175

Other funds holding LLY

BKM Wealth Management's LLY Position: Q2 2026 in Review

BKM Wealth Management reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2026, selling an estimated $9.2K and leaving 408 shares worth $489K. The position accounts for 0.17% of the portfolio, ranked #106.

BKM Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BKM Wealth Management held 408 shares of Eli Lilly worth $489K as of Q2 2026.
  • BKM Wealth Management sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.17% of BKM Wealth Management's portfolio in Q2 2026, its #106 holding.
  • BKM Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BKM Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.